First human tests begin for new hives pill
NCT ID NCT07230418
Summary
This is a very early study to check the safety of a new oral drug called HRS-3095, which is being developed for chronic hives. It will test single and multiple doses in 66 healthy volunteers to see how the body handles the drug and if it causes any side effects. The study will also look at whether food affects the drug and how it interacts with other common medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Frist Clinical Medicial College of Qingdao University
RECRUITINGQingdao, Shandong, 266555, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.